Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00000212 · ClinicalTrials.gov registry record · Phase 2

IV Cocaine Abuse: A Laboratory Model - 1

A Phase 2 study of Cocaine-Related Disorders, sponsored by New York State Psychiatric Institute.

Completed
Registry status
Phase 2
Development phase
1
Study location

NCT00000212: Completed Phase 2 study of Cocaine-Related Disorders, sponsored by New York State Psychiatric Institute.

NCT00000212 is a Phase 2 study of Cocaine-Related Disorders that has completed, run by New York State Psychiatric Institute. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00000212, a Phase 2 study of Cocaine-Related Disorders, has completed, sponsored by New York State Psychiatric Institute.

COMPLETED
Registry status
Phase 2
Development phase
1
Study location

Study Summary

The purpose of this study is to evaluate the effects of desipramine DMI maintenance on cocaine taking and on the physiological and subjective effects of cocaine, including cocaine craving.

Conditions Studied

Interventions

  • DRUG Desipramine

Study Locations (1)

New York

  • Columbia University - New York

Trial Details

FieldValue
Start Date 1987-07
Est. Completion 1988-07
Phase Phase 2

What the finished NCT00000212 record still lists

NCT00000212 is an interventional study that assigns participants to a tested intervention. An enrollment target was not published in the registry record, which is common for early-stage or observational entries.

The record links to 1 condition, with Cocaine-Related Disorders appearing as the primary indexed condition, and to 1 intervention - of which Desipramine is the first listed.

NCT00000212 reports a single indexed study location in New York.

Frequently Asked Questions

What is clinical trial NCT00000212 about?

NCT00000212 is a clinical study titled "IV Cocaine Abuse: A Laboratory Model - 1". The purpose of this study is to evaluate the effects of desipramine DMI maintenance on cocaine taking and on the physiological and subjective effects of cocaine, including cocaine craving.

What is the current status of trial NCT00000212?

This trial is currently completed. It is a Phase 2 study. The study started on 1987-07. Estimated completion is 1988-07.

What conditions does trial NCT00000212 study?

This clinical trial studies the following conditions: Cocaine-Related Disorders.

What interventions are being tested in trial NCT00000212?

The interventions under investigation include: Desipramine (DRUG).

Who is sponsoring clinical trial NCT00000212?

This trial is sponsored by New York State Psychiatric Institute, which has 364 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00000212 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00000212, the US trial registry maintained by the National Library of Medicine. NCT00000212 (unsized enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.